Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Olympia Damianidou"'
Autor:
Ioannis Fragkioudakis, Antonios Kallis, Evangelia Kesidou, Olympia Damianidou, Dimitra Sakellari, Ioannis Vouros
Publikováno v:
Dentistry Journal, Vol 11, Iss 3, p 61 (2023)
The current study aimed to investigate the effect of the combined Nd-Er: YAG laser on the surgical treatment of peri-implantitis by evaluating clinical markers and biomarkers of bone loss (RANKL/OPG). Twenty (20) patients having at least 1 implant di
Externí odkaz:
https://doaj.org/article/a109e22d36c54db0b26865e429e11641
Autor:
Evangelia Kesidou, Paschalis Theotokis, Olympia Damianidou, Marina Boziki, Natalia Konstantinidou, Charilaos Taloumtzis, Styliani-Aggeliki Sintila, Panagiotis Grigoriadis, Maria Eleptheria Evangelopoulos, Christos Bakirtzis, Constantina Simeonidou
Publikováno v:
Journal of Clinical Medicine. 12:2255
The process of ageing is characteristic of multicellular organisms associated with late stages of the lifecycle and is manifested through a plethora of phenotypes. Its underlying mechanisms are correlated with age-dependent diseases, especially neuro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5caf38ec4a96506f00317c15e8047bf4
https://doi.org/10.3390/jcm12062255
https://doi.org/10.3390/jcm12062255
Autor:
Dimitra Mitsiadou, Nikolaos Grigoriadis, Steven Petratos, Paschalis Theotokis, Olympia Damianidou, Marina Boziki, Anastasia Chatzidimitriou, Evangelia Kesidou
Publikováno v:
Brain pathology (Zurich, Switzerland). 32(4)
Experimental autoimmune encephalomyelitis (EAE) is a basic and reliable model used to study clinical and pathological hallmarks of multiple sclerosis (MS) in rodents. Several studies suggest neural precursor cells (NPCs) as a significant research too
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9626d3437652d3b5babe877319ad6e02
https://pubmed.ncbi.nlm.nih.gov/34845781
https://pubmed.ncbi.nlm.nih.gov/34845781
Publikováno v:
International Journal of Medical Sciences
Over the past two decades, the development of targeted immunotherapeutics for relapsing-remitting multiple sclerosis has been successfully orchestrated through the efficacious modulation of neuroinflammatory outcomes demonstrated in the experimental
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b893227d7489c797f8dd1c7ae3aff7b
https://pubmed.ncbi.nlm.nih.gov/34975310
https://pubmed.ncbi.nlm.nih.gov/34975310